EUCTR2008-007872-99-GB进行中（未招募）不适用
ong term follow up of subjects treated with AA4500 in studies AUX-CC-854, AUX-CC-856, AUX-CC-857/AUX-CC-858 and AUX-CC-859 - Long Term Follow Up of Subjects Previously Treated with AA4500
Auxilium UK Limited0 个研究点目标入组 850 人开始时间: 2010年3月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 850
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •This study is intended to recruit study participants who:
- •Have received at least one injection of AA4500 in one of the previously conducted phase III studies (AUX-CC-854, AUX-CC-856, AUX-CC-857/858 and AUX-CC-859)
- •Are able and willing to comply with the yearly assessments as outlined in the protocol
- •Voluntarily sign and date an informed consent agreement approved by the appropriate Institutional Review Board/Independent Ethics Committee.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 33
排除标准
- •There are no specific exclusion criteria for this study provided that the subject meets all of the inclusion criteria.
研究者
相似试验
进行中（未招募）
不适用
ong term follow up of subjects treated with AA4500 in a previous qualifying Auxilium studyDupuytren's contractureMedDRA version: 14.0Level: PTClassification code 10013872Term: Dupuytren's contractureSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2008-007872-99-DKAuxilium UK Limited850
进行中（未招募）
不适用
ong term follow up of subjects treated with AA4500 in studies AUX-CC-854, AUX-CC-856, AUX-CC-857/AUX-CC-858 and AUX-CC-859 - Long Term Follow Up of Subjects Previously Treated with AA4500EUCTR2008-007872-99-FIAuxilium UK Limited850
进行中（未招募）
不适用
ong term follow up of subjects treated with AA4500 in a previous qualifying Auxilium studyEUCTR2008-007872-99-SEAuxilium UK Limited850
进行中（未招募）
1 期
ong-term follow-up of patients previously treated with autologous T cells genetically modified with viral vectors.CTIS2024-511684-28-00Autolus Limited111
进行中（未招募）
1 期
ong-term follow-up of patients previously treated with an Autolus CAR T cell therapyEUCTR2016-004867-38-NLAutolus Limited500